Business Description
Destiny Pharma PLC
ISIN : GB00BDHSP575
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 19.9 | |||||
3-Year EPS without NRI Growth Rate | 19.8 | |||||
3-Year FCF Growth Rate | 29.1 | |||||
3-Year Book Growth Rate | -22.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.3 | |||||
9-Day RSI | 49.92 | |||||
14-Day RSI | 42.83 | |||||
6-1 Month Momentum % | -77.03 | |||||
12-1 Month Momentum % | -83.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 9.89 | |||||
Quick Ratio | 9.89 | |||||
Cash Ratio | 8.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.8 | |||||
Shareholder Yield % | -176.06 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -59.06 | |||||
ROA % | -53.37 | |||||
ROIC % | -194.65 | |||||
3-Year ROIIC % | 564.63 | |||||
ROC (Joel Greenblatt) % | -3177.36 | |||||
ROCE % | -70.33 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.42 | |||||
Price-to-Tangible-Book | 0.57 | |||||
EV-to-EBIT | 0.38 | |||||
EV-to-Forward-EBIT | -0.27 | |||||
EV-to-EBITDA | 0.38 | |||||
EV-to-Forward-EBITDA | -11.31 | |||||
EV-to-Forward-Revenue | 69.27 | |||||
EV-to-FCF | 0.46 | |||||
Price-to-Net-Current-Asset-Value | 0.57 | |||||
Price-to-Net-Cash | 0.67 | |||||
Earnings Yield (Greenblatt) % | 263.16 | |||||
FCF Yield % | -145.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Destiny Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | |||
EPS (TTM) (£) | -0.062 | ||
Beta | 0 | ||
Volatility % | 98.92 | ||
14-Day RSI | 42.83 | ||
14-Day ATR (£) | 0.015714 | ||
20-Day SMA (£) | 0.03415 | ||
12-1 Month Momentum % | -83.96 | ||
52-Week Range (£) | 0.0155 - 0.84 | ||
Shares Outstanding (Mil) | 95.77 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Destiny Pharma PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Destiny Pharma PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
Destiny Pharma PLC Frequently Asked Questions
What is Destiny Pharma PLC(LSE:DEST)'s stock price today?
When is next earnings date of Destiny Pharma PLC(LSE:DEST)?
Does Destiny Pharma PLC(LSE:DEST) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |